“The Global Fetal & Neonatal Care Equipment market is estimated to be worth $8.3bn in 2023” says new Visiongain report

05 October 2018
Pharma

Visiongain has launched a new pharma report: Global Fetal & Neonatal Care Equipment Market Forecast 2018-2028: Fetal, Neonatal, Ultrasound Devices, Fetal MRI Systems, Fetal Monitors, Fetal Pulse Oximeters, Warmer & Incubator, Phototherapy Equipment, Respiratory Devices, Neonatal Monitoring Devices, Hospitals, Clinics, Others

Fetal and neonatal care are emerging as a vital aspect in medical healthcare industry. The fetal and neonatal care comprises measures from early embryonic development through full foetus development and philosophical changes at the time of birth and one month post-delivery as a new born infant. Both fetal and neonatal growth and development are interconnected to the genetic and environmental factors. According to American Academy of Paediatrics, approximately 10% of the infants need birth assistance and ~ 1% need extensive care at the time of birth.

The lead analyst of the report commented "The fetal and neonatal care equipment market is anticipated to witness a strong growth during the forecast period. The key factor attributing to the growth of the market are increasing incidence and prevalence of pre-term birth, still birth, neonatal health complication, and other mother and neonatal pregnancy associated diseases.

The warmer & incubator held the largest share in Neonatal Care Equipment market and is expected to continue leading the market during the forecast period. However, with the increasing awareness for neonates vital analysis, the neonatal monitoring devices is anticipated to witness the second highest growth during the forecast period."

Leading companies featured in the report include Dragerwerk AG & Co. KGaA, Fisher & Paykel, GE Healthcare, Masimo Corporation, Medtronic plc, Natus Medical Inc., Philips Healthcare, Phoenix Medical Systems Pvt. Ltd.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100

About Visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

“Biobanking market set to grow to $4.2bn by 2024” says new Visiongain report

Biobanking infrastructure is improving at a global level with the establishment of large-scale national biobanks, population biobank projects, virtual biobanks and networking at national and international level.

23 May 2019

Read

“Global Urology Devices market set to grow to $9.3bn by 2023” says new Visiongain report

The market is driven by a number of factors such as aging population, technological advancements, and increasing awareness programs.

21 May 2019

Read

“In Vitro Diagnostics (IVD) market set to grow to $91bn by 2024” says new Visiongain report

In recent years, the IVD market has experienced increased consolidation among industry participants, with significant merger and acquisition (M&A) activity, especially among larger companies as they diversify and manoeuvre for stronger positions.

14 May 2019

Read

“Indian Pharmaceutical market set to grow to $71bn by 2024” says new Visiongain report

Expected increases in the level of healthcare coverage will allow greater proportion of the population to be able to afford medical care, which is still mostly paid for out-of-pocket by patients, as a greater amount of people have health insurance to cover their medical expenses.

09 May 2019

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever
WOOCS 2.2.1